REVB
Revelation Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.01
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+3.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 18, 2026 | ROPER JESS · director | A-Award | 32,011 | $0.00 |
| Aug 18, 2026 | CARVER JENNIFER · director | A-Award | 32,011 | $0.00 |
| Aug 18, 2026 | Rolke James · director, officer: Chief Executive Officer | A-Award | 208,076 | $0.00 |
| Aug 18, 2026 | Chawla Lakhmir S · director | A-Award | 32,011 | $0.00 |
| Aug 18, 2026 | Zygmont Chester Stanley III · officer: Chief Financial Officer | A-Award | 208,073 | $0.00 |
| May 1, 2026 | Zygmont Chester Stanley III · officer: Chief Financial Officer | F-InKind | 13,285 | $1.10 |
| May 1, 2026 | Rolke James · director, officer: Chief Executive Officer | F-InKind | 10,115 | $1.13 |
| Feb 5, 2026 | CARVER JENNIFER · director | F-InKind | 1,661 | $1.87 |
| Feb 5, 2026 | Rolke James · director, officer: Chief Executive Officer | F-InKind | 8,521 | $1.86 |
| Feb 5, 2026 | Zygmont Chester Stanley III · officer: Chief Financial Officer | F-InKind | 13,100 | $1.65 |
| Feb 5, 2026 | ROPER JESS · director | F-InKind | 1,591 | $1.85 |
| Feb 5, 2026 | Chawla Lakhmir S · director | F-InKind | 2,261 | $1.85 |
| Jan 12, 2026 | Rolke James · director, officer: Chief Executive Officer | A-Award | 532,829 | $0.90 |
| Jan 12, 2026 | Zygmont Chester Stanley III · officer: Chief Financial Officer | A-Award | 78,145 | $0.90 |
| Jan 12, 2026 | CARVER JENNIFER · director | A-Award | 41,981 | $0.90 |
| Jan 12, 2026 | ROPER JESS · director | A-Award | 41,981 | $0.90 |
| Jan 12, 2026 | Chawla Lakhmir S · director | A-Award | 41,981 | $0.90 |
| Oct 31, 2025 | Zygmont Chester Stanley III · officer: Chief Financial Officer | A-Award | 390,614 | $1.28 |
| Oct 31, 2025 | ROPER JESS · director | A-Award | 15,625 | $1.28 |
| Oct 31, 2025 | Chawla Lakhmir S · director | A-Award | 15,625 | $1.28 |
| Oct 31, 2025 | Rolke James · director, officer: Chief Executive Officer | A-Award | 390,614 | $1.28 |
| Oct 31, 2025 | CARVER JENNIFER · director | A-Award | 15,625 | $1.28 |
| Feb 13, 2025 | ROPER JESS · director | A-Award | 181 | $3.87 |
| Feb 13, 2025 | Rolke James · director, officer: Chief Executive Officer | A-Award | 30,095 | $3.87 |
| Feb 13, 2025 | Zygmont Chester Stanley III · officer: Chief Financial Officer | A-Award | 15,048 | $3.87 |
| Feb 13, 2025 | TIDMARSH GEORGE F · director | A-Award | 181 | $3.87 |
| Feb 13, 2025 | Chawla Lakhmir S · director | A-Award | 181 | $3.87 |
| Feb 13, 2025 | CARVER JENNIFER · director | A-Award | 181 | $3.87 |
| Dec 12, 2023 | TIDMARSH GEORGE F · director | Sale | 27,771 | $0.52 |
| Oct 18, 2023 | TIDMARSH GEORGE F · director | Sale | 1,845 | $0.65 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 18, 2026